Company

Dawnrays Pharmaceutical

Headquarters: Wan Chai, Hong Kong

Employees: 1,065

HKEX: 2348

Market Cap

HK$1.80 Billion

HKD as of July 1, 2024

US$230.4 Million

Market Cap History

Dawnrays Pharmaceutical market capitalization over time

Evolution of Dawnrays Pharmaceutical market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Dawnrays Pharmaceutical

Detailed Description

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. The company operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. It offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics; and system specific medicines for various therapeutic areas comprising cardiovascular system, anti-allergic, anti-HBV, digestive system, urinary system, anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wanchai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Dawnrays Pharmaceutical has the following listings and related stock indices.


Stock: HKEX: 2348 wb_incandescent

Details

Headquarters:

CNT Tower

Units 3001-02 30th Floor 338 Hennessy Road

Wan Chai, None

Hong Kong

Phone: 852 2111 9708

Fax: 852 2111 9870